medigraphic.com

2015, Number 4

<< Back Next >>

Rev Med MD 2015; 6.7 (4)

Prevalence of subjective insomnia and comorbidities in patients from 30 to 64 years old

Delgado-Quiñones EG, Hernández-Vega RM

Language: Spanish
References: 25
Page: 273-279
PDF size: 599.04 Kb.


ABSTRACT

Introduction. Insomnia is a frequent complaint in primary medical attention. It is very important due to is effects on quality of life, and it is also considered a risk factor for type to diabetes mellitus (DM2), arterial systemic hypertension (ASH) and obesity. According to the World Health Organization (WHO), 40% of the population has insomnia at some point of their life and 40 to 60% have some comorbidity. There are only a few prevalence studies of insomnia in Mexico. The main objective of this one is to know the prevalence of subjective insomnia and comorbidities in patients among 30 and 64 years old who attend the FMU 171.
Material and methods. Transversal, descriptive study. We included both men and women, from 30 to 64 years of age, who attended FMU 171. Both the sociodemographic formulary and the Athens Insomnia Scale (AIS) were used. The sample included 156 patients with a confidence interval of 99%. Analysis was done using descriptive statistics with SPSS version 21.
Results. 156 patients were evaluates, 62.2% women (n=97), men 37.8% (n=59=. The prevalence of subjective insomnia was of 50% (n=78), subjective insomnia and comorbidities was of 33.33% (n=52). The frequency of patients with insomnia and obesity was 23.08 (n=36), insomnia and DM2 14.74% (n=23), insomnia and hypertension 17.95% (n=28). The difficulty to start sleeping was present in 55-8% (n=87), difficulty to maintain sleep was present in 57.7% (n=90), 62.2% had day sleepiness.
Discussion. We observed a high prevalence of insomnia and comorbidities in patients under study. The most frequent one is obesity. Maintenance sleep is the most commonly affected. We found a statistically significant proportion difference for the presence of DM2 and ASH.


REFERENCES

  1. Cunnington David, Junge Moira F, Antonio T Fernando. Insomnia: prevalence, consequences and effective treatment. MJA. 2013;199:S36-S40

  2. Morin Charles M., Denise C. Jarrin. Epidemiology of Insomnia Prevalence, Course, Risk Factors, and Public Health Burden. Sleep Med Clin. 2013; 8:281–297

  3. Morin Charles M., Benca Ruth. Chronic insomnia. Seminar. Lancet 2012; 379:1129–41

  4. Kraus Stefanie S., Rabin Laura A. Sleep America: Managing the crisis of adult chronic insomnia and associated conditions. Review. Journal of Affective Disorders. 2012;138:192–212

  5. Smith Michael T. Ph.D., Perlis Michael T. Ph.D., Park Amy, B.S., Smith Michelle S., Ph. D., PenningtonJaeMi B.S., Giles Donna E. Ph.D., Buysse Daniel J. M. D. Meta-Analy s i s o f Pharmacotherapy and Behavior Therapy for Persistent Insomnia. Am J Psychiatry. 2002;159:5–11

  6. Grupo de Trabajo de la Guía de PrácticaClínica para el Manejo de Pacientes con Insomnio en Atención Primaria. Guía de PrácticaClínica para el Manejo de Pacientes con Insomnio en Atención Primaria. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Unidad de Evaluación de Tecnologi􀁌as Sanitarias. Agencia Lai􀁌n Entralgo. Comunidad de Madrid; 2009. Guías de PrácticaClínica en el SNS: UETS No 2007/5-1.

  7. Bonnet Michael H., Burton George G., Arand Donna L. Physiological and medical findings in insomnia: Implications for diagnosis and care. Sleep Medicine Reviews. 2013;30: 1-12.

  8. Durand –Arias So, Rojas-Avila Cynthia, Jimenez- Genchi Alejandro. Evaluacio􀁌n cli􀁌nica de los si􀁌ntomas relacionados con el dormir. Psiquis (Me􀁌xico), 2011; 20 (1):17-22.

  9. M. Singh, CL Drake. Insomnio comorbido con condiciones medicas. Assessment, Methodology, Training, and Policies of Sleep. Encyclopedia of Sleep.2013:1;236-238

  10. 10.S Ramnathan Iyer. Sleep and Type 2 Diabetes Mellitus- Clinical Implications. JAPI. 2012:60;42-47

  11. Shekleton Julia A, Rogers Naomi L., Rajaratham Shantha M.W. Searching for the daytime impairments of primary insomnia. Sleep Medicine Reviews. 2010;14:47–60.

  12. 12.Cappuccio Francesco P, Lanfranco D'Elia, Strazzullo Pasquale, Miller Michelle A. Sleep Duration and All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies. SLEEP 2010;33(5):585-592.

  13. 13.Ong JC., Suh S. Herramientas de diagnóstico para el insomnio. Assessment, Methodology, Training, and Policies of Sleep. Encyclopedia of Sleep.2013:1;268- 273.

  14. 14.Nenclares Alejandro Portocarrero, Alejandro Jimenez- Genchi. Estudio de validacio􀁌n de la traduccio􀁌n alespan􀁙ol de la Escala Atenas de Insomnio. Salud Mental. 2005;28 (5);34-39.

  15. Trent Un Hargens, Anthony S Kaleth, S Elizabeth Edwards, Katrina L Butner. Asociación entre los trastornos del sueño, la obesidad y el ejercicio: una revisión. Nat. Sci. sueño. 2013;5:27-35.

  16. 16.Jean-Philippe Chaput, Jean-Pierre Després, Claude Bouchard, Arne Astrup, Angelo Tremblay. Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: Analyses of the Quebec Family Study. Sleep Medicine. 2009;10:919–924.

  17. Vgontzas Alexandros N. Fernandez-Mendoza Julio, Duanping Liao, Edward O. Bixler. Insomnia with objective short sleep duration: The most biologically severe phenotype of the disorder. Sleep Medicine Reviews. 2013; 17:241-254.

  18. Alvarado Raul. Frecuencia de insomnio en México. Arch Neurocien (Mex). 1997:2(2):114-121.

  19. 19.Márquez-Romero Juan Manuel, Chiquete Erwinl. Frecuencia de insomnio y sus consecuencias diurnas en pacientes mexicanos: Subanálisis del estudio EQUINOX. Rev Mex Neuroci. 2013;14(6):314-320.

  20. 20.Jiménez- Genchi Alejandro, Grupo de Estudio Sueños de México. Características clínicas y diagnósticos de insomnio de acuerdo con la Clasificación Internacional de Trastornos del Sueño, en la práctica médica privada mexicana. Rev Mex Neuroci. 2013;14(4):183-190.

  21. 21.Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72.

  22. 22.American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015 Jan;38 Suppl:S8-S16. doi: 10.2337/dc15-S005.

  23. 23.Komada Y, Nomura T, Kusumi M, Nakashima K, Okajima I, Sasai T, Inoue Y. A two-year follow-up study on the symptomsof sleep disturbances/insomnia and their effects on daytime functioning. Sleep Med. 2012 Oct;13(9):1115-21.

  24. 24.Skapinakis P1, Rai D, Anagnostopoulos F, Harrison S, Araya R, Lewis G. Sleep disturbances and depressive symptoms: an investigation of their longitudinal association in a representative sample of the UK general population. Psychol Med. 2013 Feb;43(2):329-39.

  25. 25.Basta M1, Chrousos GP, Vela-Bueno A, Vgontzas AN. Chronic insomnia and stress system. Sleep Med Clin. 2007 Jun;2(2):279-291.




2020     |     www.medigraphic.com